PRESS RELEASE
News
-
-
PRESS RELEASE
DBV Technologies annonce la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques aux arachides
DBV Technologies annonce la fin de la dernière visite du dernier patient dans l'essai clinique de phase 3 VITESSE du patch VIASKIN® Peanut chez les enfants allergiques aux arachides, se rapprochant ainsi de la publication des résultats préliminaires -
PRESS RELEASE
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies completes last patient visit in Phase 3 VITESSE Clinical Trial of VIASKIN Peanut Patch for peanut allergic children aged 4-7 years; on track for Q4 data announcement -
-
-
PRESS RELEASE
EQS-Adhoc: Enapter AG resolves on capital measures with an issue volume of €12 million – full placement secured by institutional anchor shareholders
Enapter AG resolves on a €12 million capital increase with a zero-coupon convertible bond. Funds aim to achieve break-even in 2026, supported by institutional anchor shareholders -
PRESS RELEASE
We Mean Business Coalition (WMBC): Global businesses unite at COP30 to show the "Return on Action"
Global businesses unite at COP30 to showcase the 'Return on Action' with real-world examples of jobs, security, and growth from climate action. Companies highlight economic and social benefits during a 24-hour digital mobilization -
PRESS RELEASE
Pluxee prend acte de la communication du gouvernement brésilien à propos du Programme d’alimentation des travailleurs (PAT)
Pluxee prend acte de la communication du gouvernement brésilien sur le Programme d’Alimentation du Travailleur (PAT), exprime son inquiétude et envisage une action en justice -
-
